Robotic remote echocardiography versus standard echocardiography for heart failure care in the Guadeloupe archipelago
Comparison Between a Robotic Tele-echo-cardiography Technique and a Standard Echocardiography in the Management of Heart Failure in the Guadeloupe Archipelago Between the University Hospital of Guadeloupe and the Marie-Galante Hospital
This project will test whether robotic remote echocardiography gives the same left ventricular function measurements as standard in-person echocardiography for adults with or at risk for heart failure in the Guadeloupe islands.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de la Guadeloupe Academic / other |
| Locations | 3 sites (Grand-Bourg and 2 other locations) |
| Trial ID | NCT07265986 on ClinicalTrials.gov |
What this trial studies
This is a prospective, multicentre interventional crossover feasibility study comparing standard in-person echocardiography and two-dimensional robotic remote echocardiography, with left ventricular ejection fraction (LVEF) as the primary measurement. Patients are randomized to the order of techniques to limit order effects, and two cardiologists alternate travel to control for operator variability. The procedures are performed at Marie-Galante Hospital and collaborating cardiology centres in Guadeloupe and integrated into a telemedicine system to test technical and organizational feasibility. The study aims to measure agreement between the two methods and evaluate whether remote robotic echocardiography can be incorporated into routine heart failure management across the archipelago.
Who should consider this trial
Good fit: Adults aged 18 or older who can give informed consent, are covered by social security, and are undergoing cardiovascular check-up or have cardiovascular risk factors or suspected/stable chronic heart disease or heart failure are eligible.
Not a fit: Patients with acute unstable heart failure, those requiring urgent transfer to the university hospital, patients admitted to Marie-Galante less than five days ago, and pregnant women are excluded and unlikely to benefit from this approach.
Why it matters
Potential benefit: If successful, this approach could expand access to specialist echocardiography across the islands, reducing patient travel and speeding diagnosis and management of heart failure.
How similar studies have performed: Experimental studies have demonstrated feasibility of remote echocardiography, but applying a robotic tele-echocardiography system for coordinated heart-failure care between separate island hospitals is a novel application.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * Free, informed and written consent signed by the participant and the investigator * Person affiliated or benefiting from a social security scheme. * Patient meeting at least one of the following criteria: * Systematic cardiovascular check-up or asymptomatic patient with cardiovascular risk factor (hypertension, diabetes, obesity, tobacco, alcohol) * Clinical suspicion of heart disease and/or chronic heart failure with stability of at least one week. * Family history of heart disease and/or sudden death Exclusion Criteria: * Patient requiring urgent cardiological management with transfer to the University Hospital * Acute unstable heart failure, admission to CH Marie-Galante less than 5 days (less than one week) * Pregnant women
Where this trial is running
Grand-Bourg and 2 other locations
- Centre Hospitalier Sainte-Marie de Marie-Galante — Grand-Bourg, Guadeloupe (Recruiting)
- Centre de Cardiologie Zac Colin — Petit-Bourg, Guadeloupe (Not_yet_recruiting)
- Cabinet de cardiologie TONCOEURTONKA — Petit-Canal, Guadeloupe (Not_yet_recruiting)
Study contacts
- Study coordinator: melanie petapermal, Master degree
- Email: melanie.petapermal@chu-guadeloupe.fr
- Phone: +590590934667
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.